Welcome to the new version of CaltechAUTHORS. Login is currently restricted to library staff. If you notice any issues, please email coda@library.caltech.edu
Published January 2, 2020 | Supplemental Material + Accepted Version
Journal Article Open

Impaired cell fate through gain-of-function mutations in a chromatin reader

Abstract

Modifications of histone proteins have essential roles in normal development and human disease. Recognition of modified histones by 'reader' proteins is a key mechanism that mediates the function of histone modifications, but how the dysregulation of these readers might contribute to disease remains poorly understood. We previously identified the ENL protein as a reader of histone acetylation via its YEATS domain, linking it to the expression of cancer-driving genes in acute leukaemia. Recurrent hotspot mutations have been found in the ENL YEATS domain in Wilms tumour, the most common type of paediatric kidney cancer. Here we show, using human and mouse cells, that these mutations impair cell-fate regulation by conferring gain-of-function in chromatin recruitment and transcriptional control. ENL mutants induce gene-expression changes that favour a premalignant cell fate, and, in an assay for nephrogenesis using murine cells, result in undifferentiated structures resembling those observed in human Wilms tumour. Mechanistically, although bound to largely similar genomic loci as the wild-type protein, ENL mutants exhibit increased occupancy at a subset of targets, leading to a marked increase in the recruitment and activity of transcription elongation machinery that enforces active transcription from target loci. Furthermore, ectopically expressed ENL mutants exhibit greater self-association and form discrete and dynamic nuclear puncta that are characteristic of biomolecular hubs consisting of local high concentrations of regulatory factors. Such mutation-driven ENL self-association is functionally linked to enhanced chromatin occupancy and gene activation. Collectively, our findings show that hotspot mutations in a chromatin-reader domain drive self-reinforced recruitment, derailing normal cell-fate control during development and leading to an oncogenic outcome.

Additional Information

© The Author(s), under exclusive licence to Springer Nature Limited 2019. Received 13 December 2018. Accepted 22 October 2019. Published 18 December 2019. We thank R. Nishinakamura, A. Taguchi and Z. Li for providing reagents and discussions related to kidney differentiation assays; M. Leboeuf for technical assistance; A. Soshnev for help with figure preparation; and members of the Allis and Wen laboratories for scientific input throughout the study. We thank the Rockefeller University Genomic Resource Center, the Bio-Imaging Resource Center, the Flow Cytometry Resource Center and the MD Anderson Science Park Next-Generation Sequencing Facility (Cancer Prevention and Research Institute of Texas (CPRIT), grant RP120348). The research was supported by funds from the National Cancer Institute (grant 5R01CA204639-03), the Leukaemia and Lymphoma Society (LLS-SCOR 7006-13), and the Rockefeller University and St Jude Children's Research Hospital Collaborative on Chromatin Regulation in Pediatric Cancer (to C.D.A.); from CPRIT (grant RP160237) and the Van Andel Institute (to H.W.); and from the National Institutes of Health (NIH grants R01HG007538, R01CA193466 and R01CA228140, to W.L.). L.W. is supported by the Jane Coffin Childs Memorial Fund and an NIH Pathway to Independence Award (1K99CA226399-01). M.V.O. is supported by a K12 Award from the National Cancer Institute (K12CA184746). Reporting summary. Further information on research design is available in the Nature Research Reporting Summary linked to this paper. Data availability. The ChIP–seq and RNA-seq data have been deposited in the Gene Expression Omnibus database under accession number GSE125186. All other raw data generated or analysed during this study are included in this paper, the Extended Data figures, and the Supplementary Information. These authors contributed equally: Shasha Chong, Fan Xuan, Angela Liang. Contributions. L.W. and H.W. conceived and designed the study. L.W., H.W., A.L. and F.X. performed most of the molecular and genomic studies. L.W. and A.L. performed kidney differentiation studies. S.C. and L.W. performed imaging studies with assistance from L.F. X.C., T.S.C., H.X. and W.L. performed bioinformatics analyses. Y.L., G.C. and H.L. performed the calorimetric studies. X.W. provided technical assistance. L.G., S.-P.W., S.K.D., R.G.R. and T.W.M. generated unpublished data. M.V.O. and A.K. provided discussion and assistance with pathology analysis. L.W. wrote the paper with critical input and edits from C.D.A., H.W., R.T., L.G., X.C., A.L. and S.C. C.D.A. and H.W. jointly supervised the research. Competing interests. C.D.A. is a co-founder of Chroma Therapeutics and Constellation Pharmaceuticals and a Scientific Advisory Board member of EpiCypher. Peer review information. Nature thanks Tanja Mittag and the other, anonymous, reviewer(s) for their contribution to the peer review of this work.

Attached Files

Accepted Version - nihms-1557361.pdf

Supplemental Material - 41586_2019_1842_Fig10_ESM.jpg

Supplemental Material - 41586_2019_1842_Fig11_ESM.jpg

Supplemental Material - 41586_2019_1842_Fig12_ESM.jpg

Supplemental Material - 41586_2019_1842_Fig13_ESM.jpg

Supplemental Material - 41586_2019_1842_Fig5_ESM.jpg

Supplemental Material - 41586_2019_1842_Fig6_ESM.jpg

Supplemental Material - 41586_2019_1842_Fig7_ESM.jpg

Supplemental Material - 41586_2019_1842_Fig8_ESM.jpg

Supplemental Material - 41586_2019_1842_Fig9_ESM.jpg

Supplemental Material - 41586_2019_1842_MOESM10_ESM.xlsx

Supplemental Material - 41586_2019_1842_MOESM11_ESM.xlsx

Supplemental Material - 41586_2019_1842_MOESM12_ESM.xlsx

Supplemental Material - 41586_2019_1842_MOESM13_ESM.xlsx

Supplemental Material - 41586_2019_1842_MOESM14_ESM.xlsx

Supplemental Material - 41586_2019_1842_MOESM15_ESM.xlsx

Supplemental Material - 41586_2019_1842_MOESM1_ESM.pdf

Supplemental Material - 41586_2019_1842_MOESM2_ESM.pdf

Supplemental Material - 41586_2019_1842_MOESM3_ESM.xlsx

Supplemental Material - 41586_2019_1842_MOESM4_ESM.mov

Supplemental Material - 41586_2019_1842_MOESM5_ESM.xlsx

Supplemental Material - 41586_2019_1842_MOESM6_ESM.xlsx

Supplemental Material - 41586_2019_1842_MOESM7_ESM.xlsx

Supplemental Material - 41586_2019_1842_MOESM8_ESM.xlsx

Supplemental Material - 41586_2019_1842_MOESM9_ESM.xlsx

Files

41586_2019_1842_Fig6_ESM.jpg
Files (27.6 MB)
Name Size Download all
md5:21435228f50f865b9b8996ad1bdf79b9
1.3 MB Download
md5:8da6b6248598b1049e1786a73854d93c
784.4 kB Preview Download
md5:d3cc307217d9aa0c7bb7291c27df1a12
84.5 kB Preview Download
md5:e9edd107267ac8fcb76e2683c7cf241c
376.2 kB Preview Download
md5:59fe408f530095bb1d3fa5b1fad41869
10.4 kB Download
md5:b473998d5b052c505140b2fe1ca49078
3.5 MB Download
md5:e7bfcb925b836b42f3696c6bba3bf85d
466.1 kB Preview Download
md5:777c312b0d0e72f8743acdc92184d86b
653.7 kB Preview Download
md5:e3e3327c2fe01d8426d3edc6fa3fc720
11.7 kB Download
md5:95957c08e3d7615f641c987046e41c0c
5.7 MB Preview Download
md5:619d5cc7911a783ff49189e35fd7e64f
10.2 kB Download
md5:f6cf276053456a9290681fdb758ed316
267.9 kB Download
md5:ed322824d673af1fb42790b91ac32e16
13.5 kB Download
md5:f5f8e18136b2b653af7b8508d2f2a27e
528.4 kB Preview Download
md5:801b4c17980bab94a9fd10033386ad09
502.0 kB Download
md5:feae3cbe4a32c6dba9cac98c145cbd3a
15.8 kB Download
md5:c72a76a880662d443ee60b28d6a91d36
1.8 MB Download
md5:4c610b6182fc2a86f0b83d492c27f605
341.9 kB Preview Download
md5:a5ed74ab9df297e0778224a596e03559
912.1 kB Preview Download
md5:b5f2c08d8122c21b03427b66963b5455
13.9 kB Download
md5:c2826885ea5289d1124e4f11970dee76
512.0 kB Preview Download
md5:9549033cc373de198351fcdc68739f83
9.3 MB Preview Download
md5:0a3cd18b86384adfe2f593b634dc185f
508.2 kB Preview Download
md5:20d346f8b3ce56883de9ba0e7c124468
12.7 kB Download
md5:1c758890acf096e3357300ed4d099db8
25.8 kB Download

Additional details

Created:
August 22, 2023
Modified:
October 23, 2023